维普中文期刊产品整合服务
7篇 您的检索式:作者名="van Tiel ST"
    题名 作者 年代 出处 被引量
1Gene therapy in in vivo isolated perfusion models显示文摘van Etten B Eggermont AM van Tiel ST 2005Curr Gene Ther2005,5,:1
2Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-beating rats 显示文摘Hoving S Seynhaeve AL van Tiel ST 2005Anticancer Drugs2005,16,6:1
3Low-dose tumor necrosis factora augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats显示文摘Ten Hagen TL Van Der Veen AH Nooijen PT Van Tiel ST Seynhaeve AL Eggermont AM 2000Int J Cancer2000,87,:1
4Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats显示文摘 Seynhaeve AL van Tiel ST 2002Int J Cancer2002,97,1:1
5Tumor necrosis factor-a augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (DOXIL) correlates with altered DOXIL pharmacokinetics显示文摘Brouckaert P Takahashi N van Tiel ST Hostens J Eggermont AM Seynhaeve AL 2004Int J Cancer2004,109,:1
6Pegylated liposomal tumor necrosis factor-α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin(doxil) in soft tissue sarcoma-bearing rats显示文摘Ten Hagen TL Seynhaeve AL Van Tiel ST 2002Int J Cancer2002,97,4:1
7Pegylated Liposomal Tumor Necrosis Factor-Alpha Results in Reduced Toxicity and Synergistic Antitumor Activity after Systemic Administration in Combination with Liposomal Doxorubicin (Doxil) in Soft Tissue Sarcoma-Bearing Rats显示文摘Ten Hagen TL Seynhaeve AL van Tiel ST 2002Int J Cancer2002,97,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费